FDA Inspection 819133 — Novum Independent Institutional Review Board

Novum Independent Institutional Review Board — FEI 2521218

The FDA completed an inspection of Novum Independent Institutional Review Board on February 19, 2013 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 19, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

IRB

Citations

IDCFRDescription
731821 CFR 56.115(a)(2)Minutes of IRB meetings
732021 CFR 56.109(e)IRB approvals/disapprovals - general